Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Medpace Holdings Inc (MEDP) vs Wynn Resorts, Limited (WYNN) Price & Performance

Medpace Holdings IncTrade
Wynn Resorts, LimitedTrade

Price performance (Past 24H)

Key statistics

Medpace Holdings Inc vs Wynn Resorts, Limited — how do they compare? Medpace Holdings Inc trades at $531.56 (market cap $15.08B), while Wynn Resorts, Limited trades at $95.06 (market cap $9.93B). The key difference: Medpace Holdings Inc is the larger of the two by market cap, and Wynn Resorts, Limited pays a 1.05% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.

MEDPWYNN
Market Cap
$15.08B$9.93B
Sector
TechnologyConsumer Cyclical
52-Week High
$620.59$133.34
52-Week Low
$308.88$94.78
Enterprise Value
$14.55B$20.29B
Dividend Yield
1.05%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Medpace Holdings Inc

MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.

MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.

Wynn Resorts, Limited

Wynn Resorts (WYNN) trades at $95.61, down 1.07% today, with a bearish technical signal and mixed earnings history including three consecutive quarterly misses. The company maintains strong revenue growth from $3.8B in 2022 to $7.1B in 2025, though net margins have compressed from 11.17% to 4.58% over the same period. Recent news highlights Q1 2026 earnings beating estimates with $1.25 EPS (Zacks Investment Research, May 7, 2026), while long-term debt remains elevated at $10.50B.

Analyst consensus is bullish with a $135.50 price target (64% buy ratings), but risks include high leverage, margin pressure from Macau competition, and geopolitical challenges for the UAE expansion. The stock offers 42% upside to consensus target if operational execution improves, though investors face volatility from earnings inconsistency and macroeconomic sensitivity.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.

Read more on MEDP

About Wynn Resorts, Limited

Wynn Resorts operates luxury casinos and resorts. The company was founded in 2002 by Steve Wynn, the former CEO. The company operates four megaresorts: Wynn Macau and Encore in Macao and Wynn Las Vegas and Encore in Las Vegas. Cotai Palace opened in August 2016 in Macao, Encore Boston Harbor in Massachusetts opened June 2019. Additionally, we expect the company to begin construction on a new building next to its existing Macao Palace resort in 2023, which we forecast to open in 2026. The company also operates Wynn Interactive, a digital sports betting and iGaming platform. The company received 76% and 24% of its 2019 prepandemic EBITDA from Macao and Las Vegas, respectively.

Read more on WYNN